Related Experiment Video
Updated: May 31, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statins and myocardial remodelling: cell and molecular pathways
Karen E Porter1, Neil A Turner
1Division of Cardiovascular and Neuronal Remodelling, Leeds Institute of Genetics, Health and Therapeutics (LIGHT) and Multidisciplinary Cardiovascular Research Centre, University of Leeds, Clarendon Way, Leeds, UK. medkep@leeds.ac.uk
Expert Reviews in Molecular Medicine
|July 2, 2011
Summary
Statins offer cardiovascular protection beyond cholesterol reduction through pleiotropic effects. These drugs improve heart function by inhibiting small GTPases, benefiting heart failure patients.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- Statins are widely used to treat hypercholesterolemia and reduce cardiovascular risk.
- Their cardiovascular benefits extend beyond cholesterol-lowering, suggesting pleiotropic activities.
Purpose of the Study:
- To review the cellular and molecular mechanisms of statin's cardioprotective effects.
- To examine statin's impact on cardiomyocytes and cardiac fibroblasts.
Main Methods:
- Review of experimental studies and clinical trials on statins' effects in the heart.
- Analysis of molecular pathways, including small GTPase inhibition and prenylation.
Main Results:
- Statins reduce heart failure onset and improve cardiac dysfunction and remodeling.
- Statin-mediated effects involve inhibition of Rho family GTPases.
- Cellular effects observed in cardiomyocytes (reduced hypertrophy, apoptosis) and fibroblasts (altered proliferation, ECM synthesis).
Conclusions:
- Statins provide cardiovascular protection through pleiotropic actions, particularly via small GTPase inhibition.
- These effects translate to improved outcomes in heart failure patients.
- Further research and clinical trials are exploring expanded therapeutic applications.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...